Consistently, blockage of ACVR2B abolishes the activation of UPP and the induction of atrophy-specific ubiquitin ligases in muscles, stimulates muscle stem cell growth, and reverses prior loss of skeletal muscle and cancer-induced cardiac atrophy61, even in the presence of anti-cancer therapies62. This evidence concerns the gene ACVR2B and cancer.